On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...